YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.

Saved in:
Bibliographic Details
Title: YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.
Authors: Kazuo Tsuchiya1,2, Katsuhiro Yoshimura1,2, Yusuke Inoue1,2, Yuji Iwashita1, Hidetaka Yamada1, Akikazu Kawase3, Takuya Watanabe4, Masayuki Tanahashi4, Hiroshi Ogawa5, Kazuhito Funai3, Kazuya Shinmura1, Takafumi Suda2, Haruhiko Sugimura1 hsugimur@hama-med.ac.jp
Source: OncoImmunology. 2021, Vol. 10 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Description
ISSN:21624011
DOI:10.1080/2162402X.2021.1962656